Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD‐1 mice to single agents or drug combinations
Authors:
- Dennis L. CookDCDennis L. Cook
- Ofelia A. OliveroOOOfelia A. Olivero
- Vernon E. WalkerVWVernon E. Walker
- 19 March 2007
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 48 (3-4) , 224-238
Abstract
Experiments were performed to investigate the impact of zidovudine (AZT), lamivudine (3TC), and abacavir (ABC) on cell survival and mutagenicity in two reporter genes, hypoxanthine‐guanine phosphoribosyltransferase (HPRT) and thymidine kinase (TK), using cell cloning assays for assessing the effects of individual drugs/drug combinations in (1) TK6 human lymphoblastoid cells exposed in vitro and (2) splenic lymphocytes from male CD‐1 mice exposed transplacentally on days 12–18 of gestation. In TK6 cells, dose‐related increases in HPRT and TK mutant frequencies were found following 3 days of exposure to AZT or 3TC alone (33, 100, or 300 μM), or to equimolar amounts of AZT‐3TC. Compared with single drug exposures, AZT‐3TC coexposures generally yielded enhanced elevations in HPRT and TK mutant frequencies. Mutagenicity experiments with ABC alone, or in combination with AZT‐3TC, were complicated by the extreme cytotoxicity of ABC. Exposure of cells either to relatively high levels of AZT‐3TC short‐term (100 μM, 3 days), or to peak plasma‐equivalent levels of AZT‐3TC for an extended period (10 μM, 30 days), resulted in similar drug‐induced mutagenic responses. Among sets of mice necropsied on days 13, 15, or 21 postpartum, Hprt mutant frequencies in T‐cells were significantly elevated in the AZT‐only (200 mg/kg bw/day) and AZT‐3TC (200 mg AZT + 100 mg 3TC/kg bw/day) groups at 13 days of age. These results suggest that the mutagenicity by these nucleoside analogs is driven by cumulative dose, and raises the question of whether AZT‐3TC has greater mutagenic effects than AZT alone in perinatally exposed children. Environ. Mol. Mutagen.Keywords
This publication has 45 references indexed in Scilit:
- Clinical mitochondrial dysfunction in uninfected children born to HIV‐infected mothers following perinatal exposure to nucleoside analoguesEnvironmental and Molecular Mutagenesis, 2007
- Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother–child pairs to AZT or AZT‐3TCEnvironmental and Molecular Mutagenesis, 2007
- Plasma and cellular markers of 3′‐azido‐3′‐dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIsEnvironmental and Molecular Mutagenesis, 2007
- Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cellsEnvironmental and Molecular Mutagenesis, 2007
- Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugsToxicology and Applied Pharmacology, 2004
- Analysis of mutations in the Tk gene of Tk+/− mice treated as neonates with 3′-azido-3′-deoxythymidine (AZT)Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Genetic damage detected in CD‐1 mouse pups exposed perinatally to 3′‐azido‐3′‐deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavageEnvironmental and Molecular Mutagenesis, 2004
- Transplacental mutagenicity of N‐ethyl‐N‐nitrosourea at the hprt locus in T‐lymphocytes of exposed B6C3F1 miceEnvironmental and Molecular Mutagenesis, 2001
- Age dependent selection against HPRT deficient T lymphocytes in the HPRT± heterozygous mouseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
- Mutation assay at the thymidine kinase locus in diploid human lymphoblastsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982